The results from APRIL study, previously presented at the International Stroke Conference 2023, indicate that ApTOLL showed good safety in 151 acute ischemic stroke patients.The article also highlights that the preliminary efficacy results show that ApTOLL significantly reduces mortality and long-term functional dis.
The neuroprotectant ApTOLL, a medication that may shield the brain from tissue damage, was linked to reduced death and disability among people being treated for stroke when used with standard treatments to restore blood flow, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2023.
For the first time, a novel neuroprotectant medication that may safeguard the brain from tissue damage has been linked to reduced death and disability among people diagnosed with stroke when added to standard treatment to restore blood flow
As part of the agenda of activities carried out by the UC Faculty of Education and the Gabriela Mistral Local Public Education Service , within the framework of the "Lagar Alliance", this June 3, the first meeting of the Steering Committee was held w